Coronavirus disease 2019 (COVID-19) therapeutics - antivirals and monoclonal antibodies used to treat COVID-19
Metadata
- Coding system
- Dictionary of Medicines and Devices
- Coding system release
- 2025 10.1.0
- Organisation
- NHS Drug Refsets
- Codelist ID
- nhs-drug-refsets/covtherapydrug_cod
- Version Tag
- 20250627
- Version ID
- 73b3bb09
- Number of codes included
- 17
About
Description
Taken from the `COVTHERAPYDRUG_COD` NHS drug refset. Contains public sector information licensed under the UK Open Government Licence v3.0 (https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/).
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
* dm+d codelists can be downloaded with codes mapped to changed VMPs included - this is the default for an OpenSAFELY project. See the documentation on keeping codelists up to date for more details.
| code | term |
|---|---|
| 38376411000001105 | Remdesivir 100mg powder for concentrate for solution for infusion vials (Gilead Sciences Ltd) (AMP) |
| 38376711000001104 | Remdesivir 150mg powder for concentrate for solution for infusion vials (Gilead Sciences Ltd) (AMP) |
| 38377011000001103 | Remdesivir 100mg/20ml concentrate for solution for infusion vials (Gilead Sciences Ltd) (AMP) |
| 38377211000001108 | Remdesivir 100mg powder for solution for infusion vials (VMP) |
| 38377311000001100 | Remdesivir 100mg/20ml solution for infusion vials (VMP) |
| 38377411000001107 | Remdesivir 150mg powder for solution for infusion vials (VMP) |
| 38737211000001107 | Veklury 100mg powder for concentrate for solution for infusion vials (Gilead Sciences Ltd) (AMP) |
| 38747011000001103 | Veklury 100mg/20ml concentrate for solution for infusion vials (Gilead Sciences Ltd) (AMP) |
| 40219311000001106 | Xevudy 500mg/8ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) (AMP) |
| 40227411000001101 | Sotrovimab 500mg/8ml solution for infusion vials (VMP) |
| 40251311000001101 | Lagevrio 200mg capsules (Merck Sharp & Dohme (UK) Ltd) (AMP) |
| 40261911000001107 | Molnupiravir 200mg capsules (VMP) |
| 40324111000001109 | Nirmatrelvir 150mg tablets (Pfizer Ltd) (AMP) |
| 40325011000001107 | Paxlovid 150mg/100mg tablets (Pfizer Ltd) (AMP) |
| 40326811000001109 | Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets (VMP) |
| 40330011000001103 | Nirmatrelvir 150mg tablets (VMP) |
| 40383311000001100 | Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) (AMP) |
* Note that this is the full list of explicitly included dm+d codes for this codelist. An OpenSAFELY project will by default also include previous or subsequent codes for any included VMPs that may have changed code. See the documentation on keeping codelists up to date for more details.